Billionaires Holding KMDA

BILLIONAIRE ALLOCATION SHARES OWNED (M) % CO AVG. COST RETURN

FUNDAMENTALS

  • N/A
    PE

  • 0.07
    Yield

  • 32.2M
    Shares Outstanding

  • 100.1M
    Market Cap

News & Insights

ABOUT

KMDA

Kamada is a biopharmaceutical company. The Company develops, produces, and markets specialty plasma therapeutics, specific and general immune globulins, and other prescribed medicines using chromatographic purification technology.

Apple And Berkshire Hathaway: When Two Worlds Collide

NEWS

Icahn: Best Bet On Commodities

READ MORE